Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
May 5th, 2020
2.3K views
Here, we present a protocol for modified 980 nm diode laser enucleation to treat large volume benign prostatic hyperplasia.
Overview
This article presents a protocol for using a 980 nm diode laser for enucleation to treat large volume benign prostatic hyperplasia. The technique offers advantages such as reduced intra-operative complications and a shorter learning curve.
Key Study Components
Area of Science
- Urology
- Laser Surgery
- Benign Prostatic Hyperplasia Treatment
Background
- Benign prostatic hyperplasia is a common condition in older males.
- Lower urinary tract symptoms can significantly affect quality of life.
- Diode lasers can effectively treat this condition.
- 980 nm diode lasers absorb both water and hemoglobin.
Purpose of Study
- To present a novel laser enucleation technique.
- To improve treatment outcomes for benign prostatic hyperplasia.
- To demonstrate the advantages of diode laser technology.
Methods Used
- Confirm availability of a 980-nm diode laser with 80 to 100-watt power.
- Administer intravenous antibiotics 30 minutes prior to the procedure.
- Position the patient on the operating table.
- Conduct the enucleation procedure using the diode laser.
Main Results
- Diode laser enucleation resulted in fewer intra-operative complications.
- Shorter learning curve compared to traditional methods.
- Enhanced t-cell reception observed during the procedure.
- Effective treatment of lower urinary tract symptoms.
Conclusions
- The 980 nm diode laser is a promising tool for treating benign prostatic hyperplasia.
- It offers significant advantages over conventional surgical techniques.
- Further studies may validate long-term outcomes and efficacy.
Frequently Asked Questions
What is benign prostatic hyperplasia?
Benign prostatic hyperplasia is a non-cancerous enlargement of the prostate gland, common in older men, leading to urinary symptoms.
How does the 980 nm diode laser work?
The 980 nm diode laser effectively targets both water and hemoglobin, allowing for precise tissue removal with minimal damage to surrounding areas.
What are the benefits of using a diode laser?
Benefits include fewer complications, a shorter learning curve, and effective treatment of urinary symptoms.
What preparations are needed before the procedure?
Patients should receive intravenous antibiotics 30 minutes prior and be positioned properly on the operating table.
Is this procedure suitable for all patients?
Patient suitability should be assessed by a healthcare professional based on individual health conditions and prostate size.
What are the expected outcomes of the procedure?
Expected outcomes include reduced urinary symptoms and improved quality of life for patients.
Executive Industry Relevance
Benign prostatic hyperplasia (BPH) represents a significant therapeutic opportunity in urology, with growing demand for minimally invasive treatments that reduce complications and accelerate clinical adoption. The 980 nm diode laser enucleation technique offers a dual-modality advantage by simultaneously targeting water and hemoglobin, enabling precise tissue resection with inherent hemostasis. This approach addresses key industry priorities in therapeutic development, including procedural safety, operator learning curve reduction, and improved patient-reported outcomes such as symptom relief and quality of life.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables mechanistic interrogation of laser-tissue interactions in benign prostatic hyperplasia models.
- Operational Value: Supports preclinical evaluation of diode laser parameters for tissue ablation and coagulation.
Screening & Assay Development
- Scientific Value: Provides a standardized platform for quantifying tissue resection volume and hemostasis efficacy.
- Operational Value: Facilitates reproducible assessment of laser settings across preclinical models.
Translational & Preclinical Research
- Scientific Value: Bridges bench-to-clinic translation by validating diode laser safety and efficacy in vivo.
- Operational Value: Enables dose-response analysis of laser power settings on tissue removal and complication rates.
Pipeline & Workflow Integration
The technique fits within the urology therapeutic development continuum from target validation through preclinical efficacy testing to clinical translation, particularly for devices leveraging dual-wavelength absorption properties.
- Discovery Biology: Supports hypothesis testing on laser-mediated tissue effects in prostate models.
- Screening: Enables standardized assessment of resection efficiency and bleeding control.
- Analytics: Generates quantifiable endpoints such as prostate volume reduction and symptom score improvement.
- Translational Research: Connects preclinical laser safety data to clinical outcomes in BPH intervention.
- Enterprise Reuse: Establishes a reusable platform for evaluating laser-based urological devices.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in tissue ablation precision and hemostasis control.
- Operational Value: Standardized procedural workflow with reduced variability.
- Strategic Value: De-risks clinical translation by minimizing intraoperative complications.
- Portfolio Impact: Supports risk-adjusted advancement of laser-based BPH therapies.
Implementation Considerations
- Requires expertise in laser-tissue interaction and urological anatomy.
- Dependent on 980-nm diode laser systems with 80–100 W continuous power.
- Necessitates standardization of laser incision and enucleation techniques across users.
- Involves adaptation considerations for varying prostate lobe anatomy.
- Limited by operator skill in creating the correct surgical channel to avoid sphincter injury.
Biopharma FAQs
Why does simultaneous water and hemoglobin absorption matter for laser tissue interaction?
The 980 nm diode laser’s ability to absorb both water and hemoglobin enables precise cutting with concurrent hemostasis, reducing intraoperative bleeding during prostate enucleation. This dual absorption mechanism supports cleaner tissue resection and improved visibility during the procedure, as demonstrated in the clinical study where no intraoperative complications were observed.
How does lobe separation via laser incision enable effective enucleation?
Creating concentric circles at the bladder neck and verumontanum, connected by a posterior incision, defines the surgical plane for lobe separation. This geometric approach allows systematic enucleation of lateral lobes in opposing directions and median lobe detachment, ensuring complete tissue removal from the surgical capsule.
What quantitative outcomes indicate successful BPH intervention?
Successful intervention is indicated by significant reduction in International Prostate Symptom Score and quality of life measures, near-tripling of maximum urinary flow rate (Qmax), and near-quadrupling reduction in post-void residual volume. These metrics were significantly improved at 1, 3, and 12 months postoperatively in all 40 patients.
Why does procedural standardization reduce complications in laser enucleation?
Standardized steps—including preoperative antibiotics, precise laser incision patterns, and lobe-specific enucleation directions—minimize variability and operator-dependent errors. The study reported zero intraoperative complications and only four minor grade-one postoperative events, underscoring the value of reproducible technique in reducing surgical risk.
What statistical analysis validates long-term efficacy of diode laser enucleation?
Pre- to postoperative comparison of symptom scores, flow rates, residual volume, and prostate volume using longitudinal follow-up at 1, 3, and 12 months demonstrated sustained improvement. The modified Clavien-Dindo classification confirmed safety, with no intraoperative complications and minimal postoperative events across the cohort.
